DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/59lsr9/chile_diabetes) has announced the addition of the "Chile Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018" report to their offering.
Global Markets Direct's new report, Chile Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018 provides key market data on the Chile Diabetes Care Devices market.
The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories - Glucose Monitoring and Insulin Delivery.
The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
Scope
- Market size and company share data for Diabetes Care Devices market categories - Glucose Monitoring and Insulin Delivery.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the two market categories.
- Global corporate-level profiles of key companies operating within the Chile Diabetes Care Devices market.
- Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Becton, Dickinson and Company , Bayer HealthCare AG , Novo Nordisk A/S , Abbott Laboratories and others.
For more information visit http://www.researchandmarkets.com/research/59lsr9/chile_diabetes